Skip to main content
Fig. 2 | Harm Reduction Journal

Fig. 2

From: Progress and challenges in the elimination of hepatitis C among people who inject drugs in Germany: results of a pilot study for a national monitoring system, 10 years after the first data collection

Fig. 2

Proportion of anti-HCV positive participants among all participants (orange/ blue bars) and proportion of participants with viraemic hepatitis C infection among anti-HCV positive participants (yellow/ grey bars) by city of recruitment, DRUCK 2.0 study (2021–2022, number of participants: Augsburg N = 81, Berlin N = 143, Munich N = 105, Nuremberg N = 78, Regensburg N = 174)

Back to article page

Harm Reduction Journal

ISSN: 1477-7517